Product
Torasemide
4 clinical trials
5 indications
Indication
bioequivalenceIndication
HypertensionIndication
Genetic PredispositionIndication
Drug EffectIndication
Cardiovascular DiseasesClinical trial
Randomized Crossover 2 Period Single Dose Bioequivalence Study of 2 Formulations Torasemide Tab. 10mg (Pharmtechnology LLC,Belarus) and Toradiur® Tab. 10mg (MEDA Manufacturing Cologne, Germany) in Healthy Volunteers Under Fasting ConditionsStatus: Completed, Estimated PCD: 2021-06-20
Clinical trial
Optimal Medical Treatment of Difficult-to-treat HypertensionStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
Pharmacogenetics of Hypertension: a Single-centre Randomized Study in Patients With Essential Hypertension Treated With Spironolactone or TorasemideStatus: Completed, Estimated PCD: 2023-07-07
Clinical trial
Clinical Study of UMOD NKCC2 Interaction on Salt-sensitivity in HypertensionStatus: Completed, Estimated PCD: 2021-10-30